Categories: News

Imprivata’s New Digital Identity Maturity Assessment Tool Illuminates Security Gaps for Healthcare Organizations

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Provides key security and compliance guidance for a comprehensive digital identity strategy

LEXINGTON, Mass., Aug. 10, 2021 (GLOBE NEWSWIRE) — Imprivata®, the digital identity company for healthcare, today introduced its digital identity maturity assessment, a new tool that helps health delivery organizations (HDOs) identify critical protections missing from their digital identity strategy. The assessment tool, combined with an intelligent roadmap toward identity maturity, bolsters every modern HDO’s identity and access management (IAM) strategy by ensuring robust security, compliance, and efficiency across the healthcare environment.

“Imprivata is responding to a critical and urgent ask from CISOs, CIOs, and other IT security and compliance leaders across the healthcare industry: healthcare IT vendors must deliver more secure, scalable, and agile ways to onboard, authorize, and authenticate on-the-go clinicians, remote users, and shifting workforces,” said Gus Malezis, CEO at Imprivata. “Our new assessment tool arms healthcare IT leaders with the critical insights needed to ensure a cohesive approach to designing, building, and managing their digital identity framework.”

Healthcare delivery organizations have evolved into highly complex environments with many users and roles, locations, devices, and applications. More users with different roles need access to a wider variety of applications from any device and any location; access that must be secure but efficient. And, the proliferation of cloud apps, connected devices, and an increasingly decentralized workforce has eroded the once well-defined network perimeter. In this new ecosystem, digital identity is the anchor of an effective security strategy whereby organizations can solve their critical workflow, security, and compliance challenges.

The new assessment tool identifies gaps in the HDO’s digital identity strategy using ten highly focused questions relative to four key areas: governance and administration, identity management, authorization, and authentication and access. After taking the assessment, the user receives a custom report capturing their organization’s maturity level in each of the four categories, with insights to assist in reaching the goal of full digital identity maturity, and therefore heightened security.

“To compete in today’s healthcare marketplace, HDOs must have full confidence that their digital identity strategy is strong enough to position their organization for success,” said Wes Wright, CTO at Imprivata. “Imprivata’s new assessment tool provides an informed starting point for understanding where the healthcare organization is, along with the areas needed to craft a solid strategy that shields their environment from threats and disruption.”

Imprivata predicated its maturity assessment tool on the company’s proprietary digital identity framework – a security-and efficiency-focused blueprint to guide every HDO’s strategy for managing digital identities across complex ecosystems and planning a robust and usable IAM scheme.

Learn more about the Imprivata digital identity framework and assess your organization’s digital identity maturity level by taking the Imprivata digital identity maturity assessment.

About Imprivata
Imprivata®, the digital identity company for healthcare, provides identity, authentication, and access management solutions that are purpose-built to solve healthcare’s unique and complex workflow, security, and compliance challenges. Imprivata enables healthcare securely by establishing trust between people, technology, and information across the increasingly complex healthcare ecosystem. For more information, please visit www.imprivata.com

Media contact
Justin Ordman
Red Lorry Yellow Lorry
imprivata@rlyl.com
857 217 2886

Staff

Recent Posts

GE HealthCare drives innovation in theranostics with latest technological advances

GE HealthCare is helping advance clinical and operational excellence in theranostics and molecular imaging through…

16 hours ago

Saudi Arabia Concludes Landmark BIO 2025 Debut as Kingdom Opens Doors to Global Biotech Collaboration

From genomics to regulatory innovation, the Kingdom’s presence in Boston establishes it as a major…

16 hours ago

Enzon and Viskase Enter into Merger Agreement

Enzon and Viskase stockholders will respectively own approximately 15.9% and 84.1% of the combined companyCRANFORD,…

16 hours ago

Novo Nordisk’s subcutaneous and oral amycretin data published in The Lancet and presented at ADA 2025

Subcutaneous amycretin phase 1b/2a data on the safety, tolerability and weight loss potential in people…

16 hours ago